Related Experiment Video
Updated: Nov 2, 2025
09:09
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
1.2K
Paediatrics: how to manage septic shock.
Kam Lun Hon1, Karen Ka Yan Leung1, Felix Oberender2,3
1Paediatric Intensive Care Unit, Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong.
Drugs in Context
|June 14, 2021
Summary
Prompt diagnosis and early treatment, including antimicrobials and fluids, are crucial for improving outcomes in pediatric septic shock. Further research is needed to address gaps in pediatric sepsis management guidelines.
Area of Science:
- Pediatric Critical Care Medicine
- Infectious Diseases
- Pediatric Emergency Medicine
Background:
- Septic shock is a significant cause of critical illness in children, characterized by high rates of morbidity and mortality.
- Effective management strategies are essential to improve outcomes in pediatric patients.
Purpose of the Study:
- To provide an updated narrative review on the current management of septic shock in pediatric practice.
- To highlight key recommendations for timely diagnosis and intervention.
Main Methods:
- A comprehensive literature search was conducted on PubMed using keywords such as 'sepsis', 'septic shock', and 'systemic inflammatory response syndrome'.
- The review included various study types, including meta-analyses, randomized controlled trials, clinical trials, observational studies, and reviews, limited to English literature concerning children.
Main Results:
- Prompt diagnosis and immediate initiation of treatment are critical for improving outcomes in pediatric septic shock.
- Key recommendations emphasize early antimicrobial therapy, fluid resuscitation, vasoactive medications, and rapid source control.
Conclusions:
- Current pediatric sepsis management guidelines often rely on adult data, indicating a need for more research specific to the pediatric population.
- Addressing research gaps is vital for refining and optimizing pediatric sepsis management.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
55
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
70
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
70
01:29Drug Dosing: Infants and Children
68
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
49
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
97
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
97
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
163
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
163